A predicted copy number loss on chromosome 9 observed for distinct PDX models (Supplemental Table S2, blue) might be related to alterations of CDKN2A or ADOLB gene expression, which were known to be of clinical relevance in metastatic ccRCC (53). This evidence concerns the gene CDKN2A and nonpapillary renal cell carcinoma.